Sébastien Heritier

3.5k total citations
34 papers, 191 citations indexed

About

Sébastien Heritier is a scholar working on Physiology, Infectious Diseases and Surgery. According to data from OpenAlex, Sébastien Heritier has authored 34 papers receiving a total of 191 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 9 papers in Infectious Diseases and 9 papers in Surgery. Recurrent topics in Sébastien Heritier's work include Histiocytic Disorders and Treatments (14 papers), Parvovirus B19 Infection Studies (6 papers) and Vascular Malformations and Hemangiomas (4 papers). Sébastien Heritier is often cited by papers focused on Histiocytic Disorders and Treatments (14 papers), Parvovirus B19 Infection Studies (6 papers) and Vascular Malformations and Hemangiomas (4 papers). Sébastien Heritier collaborates with scholars based in France, Switzerland and United States. Sébastien Heritier's co-authors include Jean Donadieu, Stéphane Blanche, Alain Fischer, Pierre Frange, Guilhem Cros, Fabien Touzot, Marianne Leruez‐Ville, Marianne Debré, Jean‐François Emile and Véronique Avettand-Fènoël and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Clinical Microbiology.

In The Last Decade

Sébastien Heritier

23 papers receiving 186 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sébastien Heritier France 7 94 51 45 42 37 34 191
Yasutaka Fukui Japan 10 193 2.1× 39 0.8× 29 0.6× 16 0.4× 22 0.6× 24 322
Grace Mantus United States 10 249 2.6× 34 0.7× 16 0.4× 67 1.6× 31 0.8× 16 376
Claudio Castaños Argentina 10 56 0.6× 49 1.0× 144 3.2× 129 3.1× 21 0.6× 33 354
Verónica Giubergia Argentina 9 32 0.3× 82 1.6× 45 1.0× 138 3.3× 12 0.3× 23 264
Anu Anna George India 11 141 1.5× 77 1.5× 31 0.7× 49 1.2× 22 0.6× 37 300
Ashley Huber United States 9 40 0.4× 63 1.2× 153 3.4× 23 0.5× 87 2.4× 10 318
João Pedro Lopes Portugal 8 66 0.7× 31 0.6× 37 0.8× 77 1.8× 33 0.9× 31 311
Günsel Kutluk Türkiye 11 43 0.5× 50 1.0× 17 0.4× 75 1.8× 20 0.5× 22 247
Laila Hussaini United States 11 236 2.5× 31 0.6× 14 0.3× 63 1.5× 41 1.1× 20 351
María Angélica Palomino Chile 11 121 1.3× 350 6.9× 23 0.5× 106 2.5× 48 1.3× 18 420

Countries citing papers authored by Sébastien Heritier

Since Specialization
Citations

This map shows the geographic impact of Sébastien Heritier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sébastien Heritier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sébastien Heritier more than expected).

Fields of papers citing papers by Sébastien Heritier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sébastien Heritier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sébastien Heritier. The network helps show where Sébastien Heritier may publish in the future.

Co-authorship network of co-authors of Sébastien Heritier

This figure shows the co-authorship network connecting the top 25 collaborators of Sébastien Heritier. A scholar is included among the top collaborators of Sébastien Heritier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sébastien Heritier. Sébastien Heritier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fernandes, Helder, Pascal Pillet, Benjamin Fournier, et al.. (2025). Type I interferon as a pre‐lupus marker in anti‐nuclear antibody‐associated childhood immune thrombocytopenic purpura. British Journal of Haematology. 207(2). 543–551.
2.
Donadieu, Jean, D. A. Evseev, Caroline Hutter, et al.. (2025). Long-term off-label MAPK inhibitor therapy in children with severe/refractory Langerhans cell histiocytosis: An international observational study of 277 cases.. Journal of Clinical Oncology. 43(16_suppl). 10011–10011.
3.
Simonin, Mathieu, Sabah Boudjemaa, Charlotte Rigaud, et al.. (2024). R-CVP in Nodular Lymphocyte Predominant Hodgkin Lymphoma in Children. Blood. 144(Supplement 1). 6349–6349.
4.
Milne, Paul, Aurora Chinnici, Maria Luisa Coniglio, et al.. (2024). Prognostic Value of BRAFV600E in Peripheral Blood of Children with Langerhans Cell Histiocytosis: A Multicenter Project of the European Consortium for Histiocytosis. Blood. 144(Supplement 1). 3908–3908. 1 indexed citations
5.
Schifferli, Alexandra, Nathalie Aladjidi, Guillaume Moulis, et al.. (2024). Adolescents and Young Adults with Secondary Chronic Immune Thrombocytopenia: A Switzerland/France Collaboration Project. Blood. 144(Supplement 1). 548–548.
6.
Heritier, Sébastien, Jean Donadieu, Pierre‐Louis Léger, et al.. (2023). Lung transplantation as a rescue option in childhood critical pulmonary Langerhans cell histiocytosis. Pediatric Pulmonology. 59(1). 192–195.
7.
Cohen‐Aubart, Fleur, Sébastien Heritier, Sylvie Fraitag, et al.. (2023). OCT2 expression in histiocytoses. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 483(1). 81–86. 3 indexed citations
8.
Emile, Jean‐François, Zofia Hélias‐Rodzewicz, Benjamin H. Durham, et al.. (2023). Histiocytic neoplasm subtypes differ in their MAP2K1 mutational type. Blood Advances. 7(23). 7254–7257. 4 indexed citations
9.
Cohen‐Aubart, Fleur, et al.. (2023). PU.1 is a useful nuclear marker to distinguish between histiocytosis and histiocyte‐rich tumours. Histopathology. 83(2). 320–325. 6 indexed citations
10.
Gaymard, Bertrand, É. Bayen, Antoine Del Cul, et al.. (2022). Eye movement abnormalities in neurodegenerative langerhans cell histiocytosis. Neurological Sciences. 43(11). 6539–6546. 3 indexed citations
11.
Heritier, Sébastien & Jean Donadieu. (2021). Histiocytose langerhansienne chez l’enfant. 4(3). 248–256.
12.
Heritier, Sébastien, et al.. (2021). Prise en charge des leucémies pédiatriques. Soins Pédiatrie/Puériculture. 42(320). 35–40. 1 indexed citations
13.
Carbajal, Ricardo, Mathie Lorrot, Corinne Levy, et al.. (2020). Multisystem inflammatory syndrome in children rose and fell with the first wave of the COVID‐19 pandemic in France. Acta Paediatrica. 110(3). 922–932. 21 indexed citations
14.
15.
Heritier, Sébastien, et al.. (2018). La ponction lombaire chez l'enfant : indications, réalisation et complications.. 1 indexed citations
16.
17.
Boudjemaa, Sabah, Linda Dainese, Sébastien Heritier, et al.. (2016). Disseminated BCG osteomyelitis related to STAT 1 gene deficiency mimicking a metastatic neuroblastoma. Pediatric and Developmental Pathology. 3 indexed citations
18.
Gillet, Denis, et al.. (2016). La concertation pluriprofessionnelle au service du parcours de santé du patient douloureux chronique. Douleur et Analgésie. 29(3). 158–162. 5 indexed citations
19.
Frange, Pierre, Fabien Touzot, Marianne Debré, et al.. (2012). Prevalence and Clinical Impact of Norovirus Fecal Shedding in Children with Inherited Immune Deficiencies. The Journal of Infectious Diseases. 206(8). 1269–1274. 57 indexed citations
20.
Heritier, Sébastien & Jean Donadieu. (2012). Maladie de Gorham et anomalies vasculaires osseuses agressives. Bulletin du Cancer. 99(5). 599–604. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yasutaka Fukui Breakdown of academic impact, for papers by Grace Mantus Breakdown of academic impact, for papers by Claudio Castaños Breakdown of academic impact, for papers by Verónica Giubergia Breakdown of academic impact, for papers by Anu Anna George Breakdown of academic impact, for papers by Ashley Huber Breakdown of academic impact, for papers by João Pedro Lopes Breakdown of academic impact, for papers by Günsel Kutluk Breakdown of academic impact, for papers by Laila Hussaini Breakdown of academic impact, for papers by María Angélica Palomino
Rankless by CCL
2026